Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Koff

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Tropical Medicine and Hygiene|March 1, 1981
Propagation of dengue viruses in murine cell culturesW Koff, J L Elm, S B Halstead
The Journal of Infectious Diseases|March 1, 1992
Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccineR H Haubrich, A Takeda, W Koff, et al.
Vaccine|April 1, 1997
Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in miceM Singh, X M Li, J P McGee, et al.
Journal of Pharmaceutical Sciences|December 31, 1997
Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccineM Singh, J P McGee, X M Li, et al.
Vaccine|November 19, 1997
CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedureM Singh, C Hioe, H Qiu, et al.
Infection and Immunity|May 1, 1997
Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccineM Singh, X M Li, H Wang, et al.
Vaccine|June 2, 1998
Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal modelsM Singh, X M Li, H Wang, et al.
Vaccine|April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjectsJ S Lambert, M Keefer, M J Mulligan, et al.
AIDS Research and Human Retroviruses|November 14, 1997
Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1N Ishii, J Fukushima, T Kaneko, et al.
Vaccine|April 1, 1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesC E Hioe, H Qiu, P D Chend, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Tropical Medicine and Hygiene|March 1, 1981
Propagation of dengue viruses in murine cell culturesW Koff, J L Elm, S B Halstead
The Journal of Infectious Diseases|March 1, 1992
Studies of antibody-dependent enhancement of human immunodeficiency virus (HIV) type 1 infection mediated by Fc receptors using sera from recipients of a recombinant gp160 experimental HIV-1 vaccineR H Haubrich, A Takeda, W Koff, et al.
Vaccine|April 1, 1997
Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in miceM Singh, X M Li, J P McGee, et al.
Journal of Pharmaceutical Sciences|December 31, 1997
Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccineM Singh, J P McGee, X M Li, et al.
Vaccine|November 19, 1997
CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedureM Singh, C Hioe, H Qiu, et al.
Infection and Immunity|May 1, 1997
Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccineM Singh, X M Li, H Wang, et al.
Vaccine|June 2, 1998
Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal modelsM Singh, X M Li, H Wang, et al.
Vaccine|April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjectsJ S Lambert, M Keefer, M J Mulligan, et al.
AIDS Research and Human Retroviruses|November 14, 1997
Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1N Ishii, J Fukushima, T Kaneko, et al.
Vaccine|April 1, 1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesC E Hioe, H Qiu, P D Chend, et al.
Pageof 2